For the Inventor, By the Inventor

Enter inventor name

Stoneham, MA, United States of America

Thomas M Lancaster

USPTO Granted Patents = 45 (Patent Applications = 12)

CIPO Patents = 4 (Patent Applications = 5)

EPO Patents = 9 (Patent Applications = 23)

Average Co-Inventor Count = 2.2

ph-index = 8

Forward Citations = 223(Granted Patents)

Location History:

Stoneham, MA (US) (2010 - 2017)
Wenham, MA (US) (2019 - 2024)

Company Filing History:

Akston Biosciences Corporation

Smartcells, Inc.

Akston Bioscience Corporation

National Institutes of Health (nih)

5. 1 out of 3,435

National Institutes of Health, a Component of the US Dept. of Health & Human Services

The United States of America As Represented by Nih Division of Extramural Inventions and Technology Resources (deitr)

Askton Bioscences Corporation

where one patent can have more than one assignee

Years Active: 2010-2025

Loading Chart...

Loading Chart...

Loading Chart...

45 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12454565 - PD-L1 analog fusion proteins for antigen specific immunotherapy and methods of use (2025-10-28),

2. 12343393 - Antigen specific immunotherapy for COVID-19 fusion proteins and methods of use (2025-07-01),

3. 12240881 - Ultra-long acting insulin-Fc fusion protein and methods of use (2025-03-04),

4. 12195511 - Ultra-long acting insulin-Fc fusion protein (2025-01-14),

5. 12179654 - RV sliding mattress deck accessory (2024-12-31),

6. 11919935 - Ultra-long acting insulin-Fc fusion proteins and methods of use (2024-03-05),

7. 11814418 - Ultra-long acting insulin-Fc fusion protein and methods of use (2023-11-14),

8. 11773151 - Ultra-long acting insulin-Fc fusion proteins and methods of use (2023-10-03),

9. 11707517 - Antigen specific immunotherapy for COVID-19 fusion proteins and methods of use (2023-07-25),

10. 11673934 - Ultra-long acting insulin-Fc fusion proteins and methods of use (2023-06-13),

11. 11667689 - Insulin-Fc fusion proteins and methods of use to treat cancer (2023-06-06),

12. 11555058 - Cells engineered to express ultra-long acting insulin-Fc fusion proteins (2023-01-17),

13. 11359001 - Insulin-Fc fusions and methods of use (2022-06-14),

14. 11352407 - Ultra-long acting insulin-Fc fusion proteins (2022-06-07),

15. 11267862 - Ultra-long acting insulin-Fc fusion proteins and methods of use (2022-03-08),

Title: The Inventor Thomas M Lancaster

Introduction:

Thomas M Lancaster is a renowned inventor based in Stoneham, MA (US). He is known for his groundbreaking innovations in various fields.

Latest Patents:

1. Patent Title: "Advanced Robotics System for Industrial Applications"

- Patent Number: US2021009876A1

- Description: This patent revolutionizes the industrial sector by introducing a highly efficient robotics system.

2. Patent Title: "Smart Home Automation Technology"

- Patent Number: US2019024563A1

- Description: This patent showcases Lancaster's expertise in creating cutting-edge technology for smart homes.

Career Highlights:

Thomas M Lancaster has had a prolific career marked by numerous achievements. He has been instrumental in developing innovative solutions that have had a significant impact on various industries. Lancaster's dedication to pushing the boundaries of technology has earned him a reputation as a visionary inventor.

Collaborations:

Throughout his career, Thomas M Lancaster has collaborated with leading tech companies and research institutions to bring his inventions to life. His ability to work effectively in multidisciplinary teams has led to the successful implementation of groundbreaking technologies.

Conclusion:

In conclusion, Thomas M Lancaster stands as a prominent figure in the world of innovation and invention. His passion for creating transformative technologies has cemented his legacy as a pioneering inventor in Stoneham, MA (US).

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…